Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

NCT00958152 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: VCH-222
DRUG: VCH-222
DRUG: VCH-222
DRUG: telaprevir

Sponsor

Vertex Pharmaceuticals Incorporated